Raymond Lenhard

Professor Emeritus

1958 …2000
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Raymond Lenhard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Oncology Engineering & Materials Science
Cyclophosphamide Medicine & Life Sciences
Prednisone Medicine & Life Sciences
Information systems Engineering & Materials Science
Hodgkin Disease Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Vincristine Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences

Research Output 1958 2000

ACS cancer facts and figures

Houts, P. S., Lenhard, R. & Varricchio, C., Jan 1 2000, In : Cancer Practice. 8, 3, p. 105-108 4 p.

Research output: Contribution to journalReview article

Neoplasms

The National Comprehensive Cancer Network: What's it all about?

Houts, P. S., Lenhard, R. & Varricchio, C., Jan 1 2000, In : Cancer Practice. 8, 1, p. 1-3 3 p.

Research output: Contribution to journalArticle

Neoplasms

The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: Phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486

Oken, M. M., Leong, T., Lenhard, R., Greipp, P. R., Kay, N. E., Van Ness, B., Keimowitz, R. M. & Kyle, R. A., Sep 15 1999, In : Cancer. 86, 6, p. 957-968 12 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Interferons
Clinical Trials
Drug Therapy

American Cancer Society Nutrition Guidelines

Lenhard, R., Jan 1 1996, In : Ca-A Cancer Journal for Clinicians. 46, 6, p. 323-324 2 p.

Research output: Contribution to journalEditorial

Cancer statistics: A measure of progress

Lenhard, R., Jan 1 1996, In : Ca-A Cancer Journal for Clinicians. 46, 1, p. 3-4 2 p.

Research output: Contribution to journalEditorial

Morbidity
Neoplasms